ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Bullfrog AI Holdings Inc

Bullfrog AI Holdings Inc (BFRG)

2,86
0,29
(11,28%)
Fermé 08 Février 10:00PM
3,04
0,18
(6,29%)
Après les heures de négociation: 1:59AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
3,04
Prix Achat
2,98
Prix Vente
3,07
Volume échangé
3 789 511
2,40 Fourchette du Jour 3,07
1,4304 Plage de 52 semaines 5,52
Cap du marché
Clôture Veille
2,57
Ouverture
2,52
Dernière Transaction
25
@
3.0692
Dernière heure de transaction
Volume financier
US$ 10 454 617
VWAP
2,7588
Volume moyen (3 m)
318 238
Actions en circulation
8 713 152
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,65
Bénéfice par action (BPA)
-0,61
Chiffre d'affairess
65k
Bénéfice net
-5,36M

À propos de Bullfrog AI Holdings Inc

Bullfrog AI Holdings, Inc. is a digital biopharmaceutical company. The Company is focused on advanced artificial intelligence/machine learning (AI/ML)-driven analysis of complex data sets in medicine and healthcare. The Company's platform technology, bfLEAP, is an analytical AI/ML platform that is a... Bullfrog AI Holdings, Inc. is a digital biopharmaceutical company. The Company is focused on advanced artificial intelligence/machine learning (AI/ML)-driven analysis of complex data sets in medicine and healthcare. The Company's platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational R&D and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. The Company's therapeutic pipeline includes siRNA and Mebendazole. Its siRNA targets Beta2-spectrin in the treatment of human diseases such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Carson City, Nevada, USA
Fondé
-
Bullfrog AI Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker BFRG. Le dernier cours de clôture d'Bullfrog AI était de US$2,57. Au cours de la dernière année, les actions de Bullfrog AI ont été négociées dans une fourchette de prix de US$ 1,4304 à US$ 5,52.

Bullfrog AI compte actuellement 8 713 152 actions en circulation. La capitalisation boursière d'Bullfrog AI est de US$22,39 million. Bullfrog AI a un ratio cours/bénéfice (ratio PE) de -4.65.

BFRG Dernières nouvelles

BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week

GAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...

BullFrog AI Issues Letter to Stockholders

GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...

BullFrog AI Announces Appointment of Chief Financial Officer

GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...

BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium

GAITHERSBURG, Md., Oct. 22, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million PR Newswire JERSEY CITY, N.J., Oct...

Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

GAITHERSBURG, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using...

WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million PR Newswire JERSEY CITY, N.J., Oct...

Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

GAITHERSBURG, Md., Oct. 18, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using...

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCCThe findings suggest that...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.3814.28571428572.663.42.225397852.43575365CS
40.79535.41202672612.2453.42.01014981302.46838666CS
120.7834.51327433632.263.41.953182382.39046306CS
260.3713.85767790262.673.41.951815322.45068385CS
52-1.71-364.755.521.43041962832.9390706CS
156-2.26-42.6415094345.39.51.43049092714.6723095CS
260-2.26-42.6415094345.39.51.43049092714.6723095CS

BFRG - Frequently Asked Questions (FAQ)

What is the current Bullfrog AI share price?
The current share price of Bullfrog AI is US$ 3,04
How many Bullfrog AI shares are in issue?
Bullfrog AI has 8 713 152 shares in issue
What is the market cap of Bullfrog AI?
The market capitalisation of Bullfrog AI is USD 22,39M
What is the 1 year trading range for Bullfrog AI share price?
Bullfrog AI has traded in the range of US$ 1,4304 to US$ 5,52 during the past year
What is the PE ratio of Bullfrog AI?
The price to earnings ratio of Bullfrog AI is -4,65
What is the cash to sales ratio of Bullfrog AI?
The cash to sales ratio of Bullfrog AI is 381,33
What is the reporting currency for Bullfrog AI?
Bullfrog AI reports financial results in USD
What is the latest annual turnover for Bullfrog AI?
The latest annual turnover of Bullfrog AI is USD 65k
What is the latest annual profit for Bullfrog AI?
The latest annual profit of Bullfrog AI is USD -5,36M
What is the registered address of Bullfrog AI?
The registered address for Bullfrog AI is 321 W WINNIE LN STE 104, CARSON CITY, NEVADA, 89703
What is the Bullfrog AI website address?
The website address for Bullfrog AI is www.bullfrogai.com
Which industry sector does Bullfrog AI operate in?
Bullfrog AI operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock